Handbook of Pharmaceutical Public Policy (Pharmaceutical Health Policy)
Bei weiteren Verkäufern erhältlichAlle Exemplare dieses Buches anzeigen
Gently used. Expect delivery in 20 days. Buchnummer des Verkäufers 9780789030580-3
Über diesen Titel:
Pharmacy and pharmaceutical drug use are highly regulated and the various regulatory forces interact with diverse goals. Pharmaceutical Public Policy is a comprehensive review of the legislation, trends, business developments, and policy interpretations that have shaped drug use during the last 50 years. This unique single source explains drug regulatory activity, the major insurance and payment systems, and the impact of economics and politics on drug use in the United States. Leading experts provide a thorough and objective look at public policy issues, making this text perfect for upper level undergraduate and graduate level pharmacy, medical, and public health educators and students.
Pharmacists and pharmacy students must learn more than just the physical sciences and clinical aspects of the pharmaceutical industry. The rationale for policies, rules, and regulations is integral to understanding how to best serve patients and make the entire pharmaceutical sector more equitable and cost-effective. Pharmaceutical Public Policy examines the most pressing issues facing the industry, including control of the rising costs for drugs and ensuring correct drug usage by patients. This insightful text offers an in depth perspective of the policies and the debates that surround them. Chapters are well-referenced and many include helpful figures and tables to illustrate facts and ideas.
Topics in Pharmaceutical Public Policy include:
- pharmacy law and regulation
- Medicare and prescription drug coverage
- FDA drug approval process
- Medicaid and prescription drugs
- public health pharmacy
- Department of Veterans Affairs pharmacy programs
- Department of Defense pharmacy programs
- innovative state drug program practices
- state and federal regulation of pharmacy
- the future of the pharmaceutical industry
- managed care pharmacy
- PBM?s (pharmacy benefit managers)
- risk minimization
- importation and reimportation
- biotechnology and pharmacogenetics policy and issues
- product promotion
- competition between drugs
- drug insurance design
- patient compliance
- abuse of prescription drugs
- health care systems and insurance in Europe
- much more
Über den Autor: Thomas R. Fulda, BA, MA, was a federal civil servant for 30 years, held positions at the Social Security Administration and the Health Care Financing Administration. He conducted research on prescription drug pricing, participated in the development and implementation of the Federal Maximum Allowance Program planning for the implementation of the prescription drug provisions of the Medical Catastrophic Coverage Act of 1988, and had lead responsibilities for implementation of the Medicaid Drug Utilization Review provisions of the Omnibus Budget Reconciliation Act of 1990. He has published articles in the Journal of Managed Care Pharmacy, Journal of the American Pharmacist Association and other journals. In 1995 he was made an honorary pharmacist by APhA (American Pharmacy Association).
Albert I. Wertheimer, PhD, RPh, MBA, is Professor and Research Center Director at Temple University School of Pharmacy. He is a former Director of Outcomes Research and Management at Merck & Co., Inc., in West Point, Pennsylvania and a former Vice President of Pharmacy Managed Care at First Health Service Corporation in Glen Allen, Virginia. Prior to his work with pharmaceutical companies, he held academic appointments at the University of Minnesota and the Philadelphia College of Pharmacy where he served as Dean. He has also served as a consultant to governmental and international agencies, such as the World Health Organization, United States Congress, and the World Bank, as well as to pharmaceutical manufacturers, managed care organizations, and professional societies. He is the author or co-editor of 13 books and the author or co-author of 300 journal articles as well as being a reviewer or editorial board member of 13 journals. Dr. Wertheimer has lectured and consulted in more than 40 countries. His current research interests are pharmacoeconomics and outcomes related to disease state management.
Titel: Handbook of Pharmaceutical Public Policy (...
Verlag: CRC Press
Zustand: very good
Zahlungsarten, die dieser Verkäufer akzeptiert
Brooklyn, NY, USA
AbeBooks Verkäufer seit 13. Juni 2014
We guarantee the condition of every book as it is described on the Abebooks web sites. If
you are dissatisfied with your purchase (Incorrect Book/Not as Described/Damaged) or if the
order has not arrived, you are eligible for a refund within 30 days of the estimated delivery
date. If you have changed your mind about a book that you have ordered, please use the Ask
bookseller a question link to contact us and we will respond within 2 business days.
Shipping costs are based on books weighing 2.2 LB, or 1 KG. If your book order is heavy or oversized, we may contact you to let you know extra shipping is required.
Anbieterinformationen: Nearfine Books is a bookseller specialised in hard-to-find and out-of-print titles. We are based in London and New York.